Logo image
Senescence intensifies bleomycin-induced injury in IPF-lung epithelial cells
Journal article   Open access   Peer reviewed

Senescence intensifies bleomycin-induced injury in IPF-lung epithelial cells

Jane Read, Andrew T Reid, Claire Thomson, Marshall Plit, Que Tran La, Ross Mejia, Pankaj Saxena, Darryl A Knight, Muriel Lizé, Cecilia M Prêle, …
ERJ open research, Early View
2026
pdf
Accepted manuscript3.12 MBDownloadView
CC BY V4.0 Open Access

Abstract

Introduction Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease involving injury and a dysregulated repair response of an ageing epithelium. Here we investigate the contribution of senescence and telomere shortening to bleomycin-induced injury in alveolar epithelial cells (EpCs) derived from lung parenchymal tissue of patients with pulmonary fibrosis (PF), predominantly IPF, in vitro. Methods Injury responses of EpCs in air liquid interface (ALI) culture were assessed by ELISA, qPCR and/or immunofluorescence at 48 and 96 h post-bleomycin (30 μg·mL−1) treatment. Telomere length was evaluated by qPCR and corroborated by fluorescence in situ hybridisation (FISH). Results Bleomycin treatment increased markers of inflammation (i.e. interleukin-6 and −36γ) and senescence (i.e. p16 and p21) in EpCs from PF patients (PF-EpCs) (p<0.05); responses markedly higher than control EpCs (Ctrl-EpCs). Conversely, the effects of bleomycin on the expression of type I and type II alveolar EpC markers were supressed or down-regulated in cultures of PF-EpCs (when compared to Ctrl-EpCs), whereas the percentage of keratin 17 positive type I and II intermediate EpCs were increased (p<0.05). Telomere length was also significantly shorter in PF- than Ctrl-EpCs at baseline and further reduced post-bleomycin treatment (p<0.05). Induction of telomere shortening by cell passaging augmented bleomycin-induced PF-EpC injury, whereas pharmacological telomerase activation and selected senotherapeutics were protective. Conclusion This study provides evidence that senescence-associated telomere shortening increases the susceptibility of IPF-lung EpCs to injury. Our cell-based lung epithelial injury model has utility as a pre-clinical tool for drug discovery and the evaluation of potential senotherapeutics for IPF treatment.

Details

Metrics

1 Record Views
Logo image